Resultados de la búsqueda 611-620 of 10191 for Systemic Autoinflammatory Diseases
Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to ...
placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...
Jacksonville, Fla. The purpose of this study is to determine if LIF (Leukemia Inhibitory Factor) level is positively correlated with disease progression and ...
Jacksonville, Fla. The primary purpose of this study is to create a Mayo Clinic repository for neurodegenerative disorders such as Parkinson's disease (PD), ...
Patients with MIBG-avid, ALK wild type (or ALK unknown) disease will be randomized to one of three arms: A) current COG recommended high-risk therapy including ...
... disorders. A Study of Demyelinating Lesions as a ... disease. Determinants of Incident Stroke ... systemic therapy; (2) if patient is already ...
... disorders. A Study of Demyelinating Lesions as a ... disease. A Blood Collection Protocol To Study ... systemic therapy; (2) if patient is already ...
... disease. A Blood Collection Protocol to Study the ... disease following an attempt to perform ... systemic therapy; (2) if patient is already ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?